颈动脉CTA与高分辨率磁共振血管壁成像评估MRI定义斑块易损性的斑块水平比较
回顾性纳入同时行颈动脉CTA和高分辨率磁共振血管壁成像的患者,按改良AHA标准分类斑块并空间配准,提取CTA定量特征。265个斑块中,血管周围脂肪衰减(OR=1.05;p<0.001)和最大直径狭窄率(OR=1.03;p<0.05)是MRI定义易损性的独立预测因素。联合模型在训练集、内部验证集和前瞻性时间测试集的AUC分别为0.86、0.80和0.85。
要点
- 血管周围脂肪衰减(OR=1.05)和最大直径狭窄率(OR=1.03)是MRI定义斑块易损性的独立预测因素。
- 联合模型在训练集、内部验证集和前瞻性时间测试集的AUC分别为0.86、0.80和0.85。
- 作者认为CTA可作为MRI的可行补充工具用于常规实践中识别高风险斑块表型。
核心结论
- CTA衍生的最大直径狭窄率和血管周围脂肪衰减是MRI定义颈动脉斑块易损性的稳健独立预测因素,该支持性概念验证列线图提供了一种表征高风险斑块表型的工具。
研究设计与样本
- 回顾性纳入同时行颈动脉CTA和高分辨率磁共振血管壁成像的患者,斑块按改良AHA标准分类并配准;历史队列(2018-2024)分为训练集(n=130)和内部验证集(n=57),近期队列(2024-2025)作为前瞻性时间测试集(n=78);采用多变量逻辑回归建模,以AUC和决策曲线分析评估。
诊断标准与关键数值
- 在265个斑块中,血管周围脂肪衰减(OR=1.05;p<0.001)和最大直径狭窄率(OR=1.03;p<0.05)为MRI定义易损性的独立预测因素;联合模型AUC在训练集为0.86、内部验证集为0.80、前瞻性时间测试集为0.85。
临床应用与阅片要点
- 作者认为该斑块水平CTA模型可在MRI可及性有限的常规临床实践中作为快速、可及的工具,用于识别MRI定义的易损颈动脉斑块并辅助个性化管理。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate carotid computed tomography angiography (CTA) performance in assessing MRI-defined plaque vulnerability using high-resolution magnetic resonance vessel wall imaging (HR-MR-VWI) as the reference, and to develop a multidimensional predictive model integrating plaque composition, geometry, and perivascular adipose tissue (PVAT).
MATERIALS AND METHODS: Patients undergoing both CTA and HR-MR-VWI were retrospectively included. Plaques were classified by modified AHA criteria and co-registered to ensure spatial correspondence. Quantitative CTA features were extracted via semi-automated segmentation. A historical cohort (2018-2024) was partitioned into training (n = 130) and internal validation (n = 57) sets; a recent cohort (2024-2025) served as a prospective temporal test set (n = 78). A multivariate logistic regression model was developed and evaluated using the area under the receiver operating characteristic curve (AUC) and decision curve analysis.
RESULTS: In 265 plaques, PVAT attenuation (OR = 1.05; p < 0.001) and maximum diameter stenosis (MDS) (OR = 1.03; p < 0.05) emerged as independent predictors of MRI-defined vulnerability. The combined model achieved robust discrimination with AUCs of 0.86, 0.80, and 0.85 in the training, internal validation, and prospective temporal test sets, respectively. Calibration and decision curve analysis demonstrated excellent agreement and clinical net benefit across all cohorts.
CONCLUSION: CTA-derived MDS and PVAT attenuation are robust independent predictors of MRI-defined carotid plaque vulnerability. This supportive, proof-of-concept nomogram offers a tool for characterizing high-risk plaque phenotypes, highlighting CTA as a viable supplementary tool to MRI in routine practice.
KEY POINTS: Question Can a multidimensional carotid CTA model, integrating perivascular adipose tissue and luminal geometry, accurately identify high-risk plaque phenotypes compared to high-resolution MRI? Findings CTA-derived perivascular fat attenuation and stenosis severity are independent predictors of MRI-defined plaque vulnerability, achieving robust diagnostic performance across internal and temporal validation. Clinical relevance This plaque-level CTA model provides a rapid, accessible tool for identifying MRI-defined vulnerable carotid plaques and personalized management in routine clinical practice where MRI access is limited.
引用
- Long J, Liu X, Zhang H, et al. Plaque-level comparison of carotid CTA and high-resolution magnetic resonance vessel wall imaging for assessing MRI-defined plaque vulnerability. Eur Radiol. 2026. PMID: 41904261. doi:10.1007/s00330-026-12469-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。